Funded Projects › FP7
BIOSCENT · BIOactive highly porous and injectable Scaffolds controlling stem cell recruitment, proliferation and differentiation and enabling angiogenesis for Cardiovascular ENgineered Tissues
Congenital and acquired diseases of the heart are the leading causes of morbidity and mortality in the world today; 7.2 million people die each year due to coronary heart disease, being the first cause of mortality in population above 60 years old, and the second cause after HIV in world wide young population. There is an urgent demand for new methods to repair and replace damaged cardiovascular tissues. One of the most promising ways to achieve this goal is the development of regenerative therapies aided with novel intelligent nanobiomaterials such as bioactive scaffolds. The overall objective of this project is the development of innovative bioactive polymeric scaffolds able to guide tissue formation from dissociated stem cells, for engineering autologous cardiovascular replacements, namely vascular tissues, heart valves and cardiac muscle. Two different strategies will be followed to approach creating new engineered tissue: 1.In vitro tissue engineering: according to the most frequent tissue engineering paradigm, cells will be seeded on a scaffold composed of synthetic polymer or natural material and the tissue will be matured in vitro in a bioreactor, in order to obtain a construct that can be implanted in the appropriate anatomic location as a prosthesis; 2.In vivo tissue engineering: unseeded scaffolds that attract endogenous cells and control cell proliferation and differentiation will be implanted to repopulate and remodel an altered cardiovascular tissue. The strong innovative content of the project is in the realisation of multifunctional scaffolds which can guide complex cellular processes such as adhesion, proliferation and differentiation, processes fundamental for tissue regeneration. It is therefore necessary to design integrated material scaffolds and culture environments, which can appropriately confer biochemical, morphological, electrical and mechanical stimuli to a developing tissue.
Consortium · 18 organisations
UNIVERSITA DI PISA
IT · €1,157,800
INSTITUTUL DE CHIMIE MACROMOLECULARA PETRU PONI
RO · €161,200
FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBERG
DE · €386,090
UNIVERSITA DEGLI STUDI DI PARMA
IT · €555,800
THE UNIVERSITY OF MANCHESTER
UK · €392,200
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
UK · €2,270
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW
NL · €205,680
MEDIZINISCHE HOCHSCHULE HANNOVER
DE · €772,480
USTAV EXPERIMENTALNI MEDICINY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE
CZ · €159,760
GmbH IBT - IMMUNOLOGICAL AND BIOCHEMICALTESTSYSTEMS GMBH*
DE · €261,600
POLITECNICO DI TORINO
IT · €219,930
INSPIRALIA SOCIEDAD LIMITADA
ES · €251,167
Cambridge Research Biochemicals
UK · €196,400
SORIN BIOMEDICA CARDIO S.R.L.
IT · €498,600
SORIN GROUP ITALIA SRL
IT
PERA INNOVATION LIMITED
UK · €752,800
Chempilots a/s
DK · €179,600
IMM RECHERCHE SAS
FR · €152,354
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.